EP Patent

EP1428521A3 — Antiperspirant or deodorant composition

Assigned to Unilever PLC · Expires 2004-11-24 · 21y expired

What this patent protects

Hair removal, especially from armpits damages skin, for example by irritating it, and this can be exacerbated by the application of antiperspirants to control body odour generation. In the present invention, the deleterious effects of hair removal, eg shaving, and antiperspirancy…

USPTO Abstract

Hair removal, especially from armpits damages skin, for example by irritating it, and this can be exacerbated by the application of antiperspirants to control body odour generation. In the present invention, the deleterious effects of hair removal, eg shaving, and antiperspirancy can be ameliorated by employing antiperspirant compositions containing a natural oil and glycerol to a combined concentration of from 1.5 to 15% by weight and in a weight ratio of from 4:1 to 1:4.

Drugs covered by this patent

Patent Metadata

Patent number
EP1428521A3
Jurisdiction
EP
Classification
Expires
2004-11-24
Drug substance claim
No
Drug product claim
No
Assignee
Unilever PLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.